Vincerx Pharma Inc (NASDAQ: VINC) is -82.06% lower on its value in year-to-date trading and has touched a low of $0.22 and a high of $9.37 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VINC stock was last observed hovering at around $0.24 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $0.21, the stock is -25.13% and -45.82% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.95 million and changing -12.88% at the moment leaves the stock -85.04% off its SMA200. VINC registered -67.44% loss for a year compared to 6-month loss of -70.64%. The firm has a 50-day simple moving average (SMA 50) of $0.40034 and a 200-day simple moving average (SMA200) of $1.428945.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -38.82% gain in the last 1 month and extending the period to 3 months gives it a -70.35%, and is -19.81% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.64% over the week and 11.21% over the month.
Vincerx Pharma Inc (VINC) has around 42 employees, a market worth around $7.10M and $0.00M in sales. Distance from 52-week low is -5.91% and -97.74% from its 52-week high. The company has generated returns on investments over the last 12 months (-285.34%).
The EPS is expected to grow by 59.79% this year
33.0 institutions hold shares in Vincerx Pharma Inc (VINC), with institutional investors hold 39.19% of the company’s shares. The shares outstanding are 31.40M, and float is at 24.94M with Short Float at 2.41%. Institutions hold 32.93% of the Float.
The top institutional shareholder in the company is PROSIGHT MANAGEMENT, LP with over 2.49 million shares valued at $2.02 million. The investor’s holdings represent 11.6281 of the VINC Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 1.99 million shares valued at $1.61 million to account for 9.2897 of the shares outstanding. The other top investors are SAGE RHINO CAPITAL LLC which holds 1.7 million shares representing 7.9599 and valued at over $1.38 million, while ROCK SPRINGS CAPITAL MANAGEMENT LP holds 4.1669 of the shares totaling 0.89 million with a market value of $0.72 million.
